Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
J Biol Chem ; 284(27): 18047-58, 2009 Jul 03.
Article in English | MEDLINE | ID: mdl-19419968

ABSTRACT

Skin maintenance and healing after wounding requires complex epithelial-mesenchymal interactions purportedly mediated by growth factors and cytokines. We show here that, for wound healing, transforming growth factor-beta-activated kinase 1 (TAK1) in keratinocytes activates von Hippel-Lindau tumor suppressor expression, which in turn represses the expression of platelet-derived growth factor-B (PDGF-B), integrin beta1, and integrin beta5 via inhibition of the Sp1-mediated signaling pathway in the keratinocytes. The reduced production of PDGF-B leads to a paracrine-decreased expression of hepatocyte growth factor in the underlying fibroblasts. This TAK1 regulation of the double paracrine PDGF/hepatocyte growth factor signaling can regulate keratinocyte cell proliferation and is required for proper wound healing. Strikingly, TAK1 deficiency enhances cell migration. TAK1-deficient keratinocytes displayed lamellipodia formation with distinct microspike protrusion, associated with an elevated expression of integrins beta1 and beta5 and sustained activation of cdc42, Rac1, and RhoA. Our findings provide evidence for a novel homeostatic control of keratinocyte proliferation and migration mediated via TAK1 regulation of von Hippel-Lindau tumor suppressor. Dysfunctional regulation of TAK1 may contribute to the pathology of non-healing chronic inflammatory wounds and psoriasis.


Subject(s)
Cell Movement/physiology , Epidermal Cells , Keratinocytes/physiology , MAP Kinase Kinase Kinases/metabolism , Von Hippel-Lindau Tumor Suppressor Protein/genetics , Animals , Cell Differentiation/physiology , Cell Division/physiology , Epidermis/physiology , Humans , Keratinocytes/cytology , MAP Kinase Kinase Kinases/genetics , Mice , Mice, Knockout , Organ Culture Techniques , Paracrine Communication/physiology , RNA, Small Interfering , Signal Transduction/physiology , Sp1 Transcription Factor/metabolism , Transcriptional Activation/physiology , Transfection , Wound Healing/physiology
2.
J Cell Biol ; 184(6): 817-31, 2009 Mar 23.
Article in English | MEDLINE | ID: mdl-19307598

ABSTRACT

Skin morphogenesis, maintenance, and healing after wounding require complex epithelial-mesenchymal interactions. In this study, we show that for skin homeostasis, interleukin-1 (IL-1) produced by keratinocytes activates peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) expression in underlying fibroblasts, which in turn inhibits the mitotic activity of keratinocytes via inhibition of the IL-1 signaling pathway. In fact, PPARbeta/delta stimulates production of the secreted IL-1 receptor antagonist, which leads to an autocrine decrease in IL-1 signaling pathways and consequently decreases production of secreted mitogenic factors by the fibroblasts. This fibroblast PPARbeta/delta regulation of the IL-1 signaling is required for proper wound healing and can regulate tumor as well as normal human keratinocyte cell proliferation. Together, these findings provide evidence for a novel homeostatic control of keratinocyte proliferation and differentiation mediated via PPARbeta/delta regulation in dermal fibroblasts of IL-1 signaling. Given the ubiquitous expression of PPARbeta/delta, other epithelial-mesenchymal interactions may also be regulated in a similar manner.


Subject(s)
Epithelial Cells/metabolism , Fibroblasts/metabolism , Interleukin-1/metabolism , PPAR delta/metabolism , PPAR-beta/metabolism , Signal Transduction , Skin/metabolism , Wound Healing , Animals , Autocrine Communication , Cell Differentiation , Cell Proliferation , Cells, Cultured , Cytokines/metabolism , Epithelial Cells/enzymology , Epithelial Cells/immunology , Fibroblasts/enzymology , Fibroblasts/immunology , Gene Knockdown Techniques , Homeostasis , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Interleukin 1 Receptor Antagonist Protein/genetics , Interleukin 1 Receptor Antagonist Protein/metabolism , Interleukin-1/genetics , Interleukin-1alpha/metabolism , Interleukin-1beta/metabolism , MAP Kinase Kinase Kinases/metabolism , Mice , Mice, Knockout , Organ Culture Techniques , PPAR delta/deficiency , PPAR delta/genetics , PPAR-beta/deficiency , PPAR-beta/genetics , Paracrine Communication , Promoter Regions, Genetic , RNA Interference , Skin/enzymology , Skin/immunology , Time Factors , Transcription Factor AP-1/metabolism , Transcriptional Activation
SELECTION OF CITATIONS
SEARCH DETAIL